STAT+: Medicare is urged to consider Amgen patent maneuvers when negotiating the price for a drug
STAT
OCTOBER 31, 2023
Later, Amgen reworked old patent applications and, by doing so, succeeded in extending patent protection for the medicine from 2019 until 2029, according to an analysis by the advocacy group. Continue to STAT+ to read the full story…
Let's personalize your content